Researchers discover skin biomarkers in infants that predict early development of food allergies

by National Jewish HealthGraphical abstract. Credit:Journal of Allergy and Clinical Immunology(2024). DOI: 10.1016/j.jaci.2024.02.014Food allergies occur often in childhood and can be

Updated on: March 30,2024

Researchers discover skin biomarkers in infants that predict early development of food allergies

by National Jewish HealthGraphical abstract. Credit:Journal of Allergy and Clinical Immunology(2024). DOI: 10.1016/j.jaci.2024.02.014Food allergies occur often in childhood and can be

Updated on:March 30,2024

New study questions the efficacy of many osteoarthritis treatments

by Lund UniversityCredit: Pixabay/CC0 Public DomainRecruiting osteoarthritis patients with a lot of pain to clinical studies may give incorrect results if the researcher does not account for the

Updated on: May 26,2024

New study questions the efficacy of many osteoarthritis treatments

by Lund UniversityCredit: Pixabay/CC0 Public DomainRecruiting osteoarthritis patients with a lot of pain to clinical studies may give incorrect results if the researcher does not account for the

Updated on:May 26,2024

Adherence to mediterranean diet not linked to risk of RA

(HealthDay)—Adherence to a Mediterranean diet is not associated with incidence of rheumatoid arthritis (RA) in U.S. women, according to a study published in the May issue ofArthritis Care &

Updated on: April 08,2024

Adherence to mediterranean diet not linked to risk of RA

(HealthDay)—Adherence to a Mediterranean diet is not associated with incidence of rheumatoid arthritis (RA) in U.S. women, according to a study published in the May issue ofArthritis Care &

Updated on:April 08,2024

Long-term rituximab safe for patients with wegener's

Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener&#3

Updated on: March 28,2024

Long-term rituximab safe for patients with wegener's

Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener&#3

Updated on:March 28,2024

Study finds primary cilia restrict autoinflammation by mediating PD-L1 expression

by Science China PressLoss of primary cilia results in the downregulation of PD-L1 expression, which contributes to unrestrained local T cell proliferation and activation. Credit: Science China P

Updated on: June 15,2024

Study finds primary cilia restrict autoinflammation by mediating PD-L1 expression

by Science China PressLoss of primary cilia results in the downregulation of PD-L1 expression, which contributes to unrestrained local T cell proliferation and activation. Credit: Science China P

Updated on:June 15,2024

Scientists discover two cellular defects appear to drive disease in lupus

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic im

Updated on: July 11,2024

Scientists discover two cellular defects appear to drive disease in lupus

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic im

Updated on:July 11,2024

A new, potent weapon against lymphomas

by Max Delbrück Center for Molecular MedicineAnti-CXCR5 CAR-T cells (green) attack lymphoma cells (magenta) within the stroma cell network of the B cell follicle (light blue). Credit: AG Höpken /

Updated on: May 05,2024

A new, potent weapon against lymphomas

by Max Delbrück Center for Molecular MedicineAnti-CXCR5 CAR-T cells (green) attack lymphoma cells (magenta) within the stroma cell network of the B cell follicle (light blue). Credit: AG Höpken /

Updated on:May 05,2024

AD most commonly used term in literature for atopic dermatitis

(HealthDay)—Atopic dermatitis (AD) is most commonly referred to as AD in the literature, according to a review published online July 8 inAllergy.Robert Kantor, from the Northwestern University F

Updated on: April 08,2024

AD most commonly used term in literature for atopic dermatitis

(HealthDay)—Atopic dermatitis (AD) is most commonly referred to as AD in the literature, according to a review published online July 8 inAllergy.Robert Kantor, from the Northwestern University F

Updated on:April 08,2024

Researchers identify new target for rheumatoid arthritis

by Hospital for Special SurgeryCo-senior author and Program Director Carl Blobel, M.D., Ph.D., works with collaborator Lionel Ivashkiv, M.D., in the Arthritis and Tissue Degeneration Program lab

Updated on: March 24,2024

Researchers identify new target for rheumatoid arthritis

by Hospital for Special SurgeryCo-senior author and Program Director Carl Blobel, M.D., Ph.D., works with collaborator Lionel Ivashkiv, M.D., in the Arthritis and Tissue Degeneration Program lab

Updated on:March 24,2024

Recognizing young people's perspectives in inflammatory arthritis

by EULARFigure 1 Example outlining the different steps of the analysis from a meaning unit to lower and higher level concepts. PROMs, patient-reported outcome measures.Inflammatory arthritis is the na

Updated on: May 26,2024

Recognizing young people's perspectives in inflammatory arthritis

by EULARFigure 1 Example outlining the different steps of the analysis from a meaning unit to lower and higher level concepts. PROMs, patient-reported outcome measures.Inflammatory arthritis is the na

Updated on:May 26,2024

A bacterial toxin turning cells into swiss cheese

by Kanazawa UniversityResearchers from Kanazawa University developed a novel tool to study how the innate immune system fights bacterial toxins. They purified the pore-forming toxin Monalysin fro

Updated on: May 05,2024

A bacterial toxin turning cells into swiss cheese

by Kanazawa UniversityResearchers from Kanazawa University developed a novel tool to study how the innate immune system fights bacterial toxins. They purified the pore-forming toxin Monalysin fro

Updated on:May 05,2024

First-in-human trial with CAR macrophages shows promise targeting solid tumors

by Caren Begun,University of PennsylvaniaCredit: Pixabay/CC0 Public DomainPreliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability a

Updated on: April 09,2024

First-in-human trial with CAR macrophages shows promise targeting solid tumors

by Caren Begun,University of PennsylvaniaCredit: Pixabay/CC0 Public DomainPreliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability a

Updated on:April 09,2024